Bellicum Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Bellicum Pharmaceuticals

Access the complete profile.

Bellicum Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	3730 Kirby Dr. Suite 1200 Houston, TX 77098

Bellicum Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Bellicum Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Bellicum Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Bellicum Pharmaceuticals is a publicly traded company on NGM using the ticker symbol BLCM. Detailed information on company financials and operating reports can be found here: NGM: BLCM

Bellicum Pharmaceuticals Annual Revenue and Growth Rate

Bellicum Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Bellicum Pharmaceuticals's revenues are gauged from an analysis of company filings.

Investor Activity

Bellicum Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
September 3, 2014	76	100%	$94 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Bellicum Pharmaceuticals is developing and marketing. Bellicum Pharmaceuticals doesn't have any recent trademark applications, indicating Bellicum Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RIVOCEL Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for immunotherapy, including T Cell therapy	12/21/2018
REGALTRA Pharmaceutical preparations for use in connection with cellular transplants	11/02/2017
REPCELIT Cells for medical or clinical use	10/20/2017

See all trademarks and details in the Full Report.

Market Share of Bellicum Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Bellicum Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Bellicum Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EMPOWER CLINIC SERVICES	Houston, TX	100
SUNDAY RILEY MODERN SKINCARE	Houston, TX	57
GENE BY GENE	Houston, TX	40
BELLICUM PHARMACEUTICALS	Houston, TX	11
WOODFIELD PHARMACEUTICAL	Houston, TX	8
KIROMIC BIOPHARMA	Houston, TX	4

Future Competition: Bellicum Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Bellicum Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)